Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL9P2 (Ribosomal protein L9 pseudogene 2) is a processed pseudogene corresponding to the functional ribosomal protein L9 gene (RPL9), a component of the 60S ribosomal subunit. Pseudogenes such as RPL9P2 are segments of DNA that are similar to known genes but typically contain defects (e.g., premature stop codons or frameshifts) that prevent them from coding for functional proteins. In the genome, many ribosomal protein genes have multiple processed pseudogenes dispersed throughout due to frequent retrotransposition events[1][5]. RPL9P2 is not transcribed into a functional protein and has no known biological activity, function, or disease association. Therefore, it is not considered a receptor, enzyme, or therapeutic target. RPL9P2 is formally annotated as a pseudogene in genomic databases, and there is no evidence it encodes an active protein or participates in any physiological or pathological processes[1][5]. Pseudogenes may occasionally be transcribed or have regulatory roles, but no such function is documented for RPL9P2 specifically[1][5]. Typical ribosomal proteins, such as RPL9, are important in the protein translation machinery; however, their pseudogenes are gene relics with no known translational role[4][7]. There are no known drugs, mechanisms of action, or safety concerns relevant to this pseudogene.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L9 pseudogene 2 (RPL9P2).